Semaglutide Program

Semaglutide GLP-1 weight management and metabolic support A GLP-1 receptor agonist that reduces hunger signals, slows gastric emptying, and improves insulin sensitivity. Clinical trials demonstrated average weight loss of 15 to 17 percent of body weight over 68 weeks. Key Benefits Significantly reduces appetite and food cravings Supports sustained weight loss over time Improves blood sugar regulation and insulin sensitivity Once weekly injection for maximum convenience Protocol Frequency Dose Cycle Once / week Titrated Ongoing Pricing Monthly $199 Flexible supply 12 Week Package $1,899 No auto-renewal